Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Valenciano, Marta"'
Autor:
Merdrignac L; Epidemiology Department, Epiconcept, Paris, France. Electronic address: l.merdrignac@epiconcept.fr., Acosta L; Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain; Universitat Politècnica de Catalunya- BarcelonaTech (UPC), Barcelona, Spain., Habington A; Children's Health Ireland, Crumlin, Dublin, Ireland., Garcìa Cenoz M; Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain., Pandolfi E; Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children Hospital, Rome, Italy., Fabiánová K; National Institute of Public Health, Prague, Czech Republic., Jordan I; Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain; University of Barcelona, Barcelona, Spain., O'Sullivan N; Children's Health Ireland, Crumlin, Dublin, Ireland., Navasués A; Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain., Tozzi AE; Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children Hospital, Rome, Italy., Zavadilová J; National Institute of Public Health, Prague, Czech Republic., Jané M; Public Health Agency of Catalonia (ASPCAT), Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain; University of Barcelona, Barcelona, Spain., Cotter S; Health Protection Surveillance Centre, Dublin, Ireland., Pitillas NI; Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona, Spain., Rizzo C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Křížová P; National Institute of Public Health, Prague, Czech Republic., Hanslik T; Sorbonne University, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France., Muñoz Almagro C; Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain; CIBER of Epidemiology and Public Health (CIBERESP), Barcelona, Spain; Medicine Department, Universitat Internacional de Catalunya, Barcelona, Spain., Pastore L; European Centre for Diseases Control and Prevention, Stockholm, Sweden., Bacci S; European Centre for Diseases Control and Prevention, Stockholm, Sweden., Moren A; Epidemiology Department, Epiconcept, Paris, France., Valenciano M; Epidemiology Department, Epiconcept, Paris, France.
Publikováno v:
Vaccine [Vaccine] 2022 Oct 19; Vol. 40 (44), pp. 6374-6382. Date of Electronic Publication: 2022 Sep 29.
Autor:
Patel MK; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland. Electronic address: patelm@who.int., Bergeri I; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland., Bresee JS; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, USA., Cowling BJ; School of Public Health, The University of Hong Kong, Pokfulam, Hong Kong, China., Crowcroft NS; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland., Fahmy K; World Health Organization Regional Office for the Eastern Mediterranean, Monazamet El Seha El Alamia Str, Extension of Abdel Razak El Sanhouri Street, P.O. Box 7608, Nasr City, Cairo 11371, Egypt., Hirve S; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland., Kang G; Christian Medical College, Ida Scudder Road, Vellore, Tamil Nadu 632004, India., Katz MA; World Health Organization Regional Office of Europe, UN City, Marmorvej 51, Copenhagen DK-2100, Denmark., Lanata CF; Instituto de Investigación Nutricional, Av. la Molina 1885, La Molina 15024, Peru., L'Azou Jackson M; The Coalition for Epidemic Preparedness Innovations (CEPI), Gibbs building, 215 Euston Rd, Bloomsbury, London NW1 2BE, United Kingdom., Joshi S; World Health Organization Regional Office for South-East Asia, World Health House, Indraprastha Estate, Mahatma Gandhi Marg, New Delhi 110 002, India., Lipsitch M; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA., Mwenda JM; World Health Organization Regional Office for Africa, Cité du Djoué, P.O. Box 06, Brazzaville, Republic of Congo., Nogareda F; Consultant to the Pan American Health Organization, 525 23rd Street NW, Washington, DC 20037, USA., Orenstein WA; Emory Vaccine Center, 954 Gatewood Road, Atlanta, GA 30329, USA., Ortiz JR; Center for Vaccine Development & Global Health, University of Maryland School of Medicine, 685 W. Baltimore St., Room #480, Baltimore, MD 21201, USA., Pebody R; World Health Organization Regional Office of Europe, UN City, Marmorvej 51, Copenhagen DK-2100, Denmark., Schrag SJ; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, USA., Smith PG; MRC International Epidemiology & Statistics Group, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom., Srikantiah P; Bill & Melinda Gates Foundation, 500 5th Ave N., Seattle, WA 98109, USA., Subissi L; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland., Valenciano M; Epiconcept, 25 rue de Titon, Paris 75011, France., Vaughn DW; Bill & Melinda Gates Foundation, 500 5th Ave N., Seattle, WA 98109, USA., Verani JR; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, USA., Wilder-Smith A; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland., Feikin DR; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.
Publikováno v:
Vaccine [Vaccine] 2021 Jul 05; Vol. 39 (30), pp. 4013-4024. Date of Electronic Publication: 2021 Jun 01.
Autor:
Valenciano M; Epidemiology Department, EpiConcept, Paris, France. Electronic address: m.valenciano@epiconcept.fr., Kissling E; Epidemiology Department, EpiConcept, Paris, France., Reuss A; Department for Infectious Disease Epidemiology Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Jiménez-Jorge S; National Centre of Epidemiology/CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain., Horváth JK; Department of Public Health, Strategic Planning and Epidemiology, Office of the Chief Medical Officer, Budapest, Hungary., Donnell JM; Health Protection Surveillance Centre, Dublin, Ireland., Pitigoi D; UMF Carol Davila, INCDMI Cantacuzino, Bucharest, Romania., Machado A; Department of Epidemiology, National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal., Pozo F; National Centre for Microbiology, National Influenza Centre-Institute of Health Carlos III, Madrid, Spain.
Publikováno v:
Vaccine [Vaccine] 2015 Jun 04; Vol. 33 (24), pp. 2813-22. Date of Electronic Publication: 2015 Apr 28.
Autor:
Hanquet G; University of Ghent and University of Antwerp, Belgium. Electronic address: ghanquet@skynet.be., Valenciano M, Simondon F, Moren A
Publikováno v:
Vaccine [Vaccine] 2013 Nov 19; Vol. 31 (48), pp. 5634-42. Date of Electronic Publication: 2013 Jul 13.
Autor:
Kelly H; Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC, Australia. heath.kelly@mh.org.au, Valenciano M
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2012 Jan; Vol. 12 (1), pp. 5-6. Date of Electronic Publication: 2011 Oct 25.
Autor:
Valenciano M; EpiConcept, Paris, France. m.valenciano@epiconcept.fr, Kissling E, Ciancio BC, Moren A
Publikováno v:
Vaccine [Vaccine] 2010 Oct 28; Vol. 28 (46), pp. 7381-8. Date of Electronic Publication: 2010 Sep 17.
Autor:
Savulescu C; European Centre for Disease Prevention and Control, European Programme for Intervention Epidemiology Training, Stockholm, Sweden. csavulescu@isciii.es, Valenciano M, de Mateo S, Larrauri A
Publikováno v:
Vaccine [Vaccine] 2010 Apr 01; Vol. 28 (16), pp. 2903-7. Date of Electronic Publication: 2010 Feb 11.